NeutropeniaAgranulocytosisFebrile NeutropeniaChemotherapy-Induced Febrile NeutropeniaFeverGranulocyte Colony-Stimulating FactorAntineoplastic Combined Chemotherapy ProtocolsDrug Administration ScheduleTaxoidsPaclitaxelInfusions, IntravenousTreatment OutcomeCamptothecinThrombocytopeniaMaximum Tolerated DoseNeoplasmsLeukocyte CountDeoxycytidineAntineoplastic Agents, PhytogenicCisplatinAntineoplastic AgentsFelty SyndromeLeukocyte ElastaseNeutrophilsFluorouracilMycosesLeukopeniaVinblastineHematologic DiseasesDose-Response Relationship, DrugReceptors, Granulocyte Colony-Stimulating FactorCarboplatinFever of Unknown OriginSurvival AnalysisDoxorubicinCyclophosphamideOrganoplatinum CompoundsLeucovorinBacterial InfectionsOpportunistic InfectionsDisease-Free SurvivalTopotecanLung NeoplasmsHematologic NeoplasmsSurvival RateNauseaEtoposideEpirubicinRecombinant ProteinsBlood Cell CountImmunocompromised HostSalvage TherapyAntimetabolites, AntineoplasticNeoplasm MetastasisAdministration, OralAntifungal AgentsArea Under CurveBone MarrowCarcinoma, Non-Small-Cell LungOxonic AcidNeoplasm StagingTegafurRetrospective StudiesCombined Modality TherapyIfosfamideGranulocytesAspergillosisEpothilonesNeoplasm Recurrence, LocalAntibiotic ProphylaxisRemission InductionAnti-Bacterial AgentsAlopeciaFungemiaBacteremiaDrug Therapy, CombinationVincristineBreast NeoplasmsProspective StudiesStomatitisTime FactorsDisease ProgressionVomitingMitoxantroneCarcinoma, Small CellBone Marrow DiseasesLymphoma, Non-HodgkinAdenocarcinomaAnemiaGlycogen Storage Disease Type IPrednisoneInfectionAntibodies, Monoclonal, Murine-DerivedAmphotericin BPlatelet CountDrug EvaluationBarth SyndromeThalidomideLeukemia, Myeloid, AcuteDiarrhea